Nanoparticles-mediated dual drug administration boosts therapeutic efficacy in drug resistant melanoma

Giulia Lovati, Pietro Milesi, Paolo Fossati, Daria Duca, Federica Maria Prandini, Luca Brambilla, Lodovico Gatti, Erika Mileti, Giuseppina Giardina, Mirko Doni, Mattia Tiboni, Luca Casettari, Martina Beccalli, Giovanna Jodice, Massimo Barberis, Andrea Francesco Benvenuto, Sara Sigismund, Federica Marocchi, Luisa Lanfrancone, Francesca Baldelli Bombelli

Open source

DOI: 10.1016/j.jconrel.2026.115275
Published: 2026-10
Container: Journal of Controlled Release
Publisher: Elsevier BV
Open access: unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

supportingDOI registered: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
supportingDOI resolves: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
supportingMetadata completeness: All 6 scored descriptive metadata groups are present. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1016/j.jconrel.2026.115275,
  title = {Nanoparticles-mediated dual drug administration boosts therapeutic efficacy in drug resistant melanoma},
  author = {Giulia Lovati and Pietro Milesi and Paolo Fossati and Daria Duca and Federica Maria Prandini and Luca Brambilla and Lodovico Gatti and Erika Mileti and Giuseppina Giardina and Mirko Doni and Mattia Tiboni and Luca Casettari and Martina Beccalli and Giovanna Jodice and Massimo Barberis and Andrea Francesco Benvenuto and Sara Sigismund and Federica Marocchi and Luisa Lanfrancone and Francesca Baldelli Bombelli},
  year = {2026},
  journal = {Journal of Controlled Release},
  doi = {10.1016/j.jconrel.2026.115275},
  url = {https://doi.org/10.1016/j.jconrel.2026.115275}
}

RIS

TY  - JOUR
TI  - Nanoparticles-mediated dual drug administration boosts therapeutic efficacy in drug resistant melanoma
AU  - Giulia Lovati
AU  - Pietro Milesi
AU  - Paolo Fossati
AU  - Daria Duca
AU  - Federica Maria Prandini
AU  - Luca Brambilla
AU  - Lodovico Gatti
AU  - Erika Mileti
AU  - Giuseppina Giardina
AU  - Mirko Doni
AU  - Mattia Tiboni
AU  - Luca Casettari
AU  - Martina Beccalli
AU  - Giovanna Jodice
AU  - Massimo Barberis
AU  - Andrea Francesco Benvenuto
AU  - Sara Sigismund
AU  - Federica Marocchi
AU  - Luisa Lanfrancone
AU  - Francesca Baldelli Bombelli
PY  - 2026
JO  - Journal of Controlled Release
DO  - 10.1016/j.jconrel.2026.115275
UR  - https://doi.org/10.1016/j.jconrel.2026.115275
ER  -

APA

Lovati, G., Milesi, P., Fossati, P., Duca, D., Prandini, F. M., Brambilla, L., Gatti, L., Mileti, E., Giardina, G., Doni, M., Tiboni, M., Casettari, L., Beccalli, M., Jodice, G., Barberis, M., Benvenuto, A. F., Sigismund, S., Marocchi, F., Lanfrancone, L., & Bombelli, F. B. (2026). Nanoparticles-mediated dual drug administration boosts therapeutic efficacy in drug resistant melanoma. Journal of Controlled Release. https://doi.org/10.1016/j.jconrel.2026.115275

Source records

crossref · retrieved 2026-09-25T23:46:08.775Z